Intellia Achieves Gene-Editing Breakthrough With First In Vivo CRISPR Therapy

Promise Of Safe And Effective Gene Editing Takes Step Forward

 
• By Andrew McConaghie
Intellia Therpeutics
Intellia's in vivo CRISPR therapies could rival other modalities, such as viral vector-based gene therapies and RNAi therapies. • Source: Intelllia

More from Business

More from Scrip